dorsaVi (ASX:DVL) has completed a strategic analysis, which indicates its resistive random-access memory (RRAM) and neuromorphic computing roadmap could more than double battery life in exoskeleton and wearable robotics applications | https://t.co/bY3Is86MRc @dorsavi $DVL
_ @EBRSystemsInc (ASX: EBR) has completed the institutional component of its ~A$150m fully underwritten raise, raising ~A$106.4m with strong support. The retail entitlement offer is fully underwritten and expected to raise ~A$43.6m.
ASX announcement: https://t.co/faNlgDlnam
FortifAI Limited (ASX: FTI) has appointed Silicon Valley technology executive Kelly Herrell as its new Chief Executive Officer. He will lead efforts by FortifAI and its AI infrastructure subsidiary Nol8 | Announcement: https://t.co/Ed85TMne52 #fortifAI $FTI
_ @EBRSystemsInc (ASX:EBR) has achieved a major reimbursement milestone, with the U.S. Centers for Medicare & Medicaid Services (CMS) initiating a National Coverage Determination (NCD) process for the WiSE® System.
ASX announcement: https://t.co/KanwPSmJci
_ @Optiscan_ (ASX:OIL) has reached the halfway milestone in its first in-human breast cancer imaging study at The Royal Melbourne Hospital.
ASX announcement: https://t.co/45Ob34ILQ3
_ @4DMedicalXV (ASX:4DX) launched CLEAR, a clinical evidence program to accelerate CT:VQ™ into acute PE, expanding US opportunity to ~US$3bn.
Webinar – 11:00am AEST Tue 9 June 2026. CEO Dr Andreas Fouras hosts live Q&A.
Register: https://t.co/xvbudufqbF
_ @Optiscan_ (ASX:OIL) has announced the second anniversary of its Know-How Agreement with Mayo Clinic, marking continued progress in the co-development of a robotic-compatible digital endomicroscopic imaging system for surgery.
ASX announcement: https://t.co/Q0YLlMFPFh
_ @4DMedicalXV (ASX:4DX) has announced a major expansion into Europe through the acquisition of Austrian medical technology company contextflow, establishing an immediate commercial and clinical platform across the region.
ASX announcement: https://t.co/PPTYWxj2tW
EV Resources Limited (ASX:EVR) has achieved a major permitting milestone at its Tecomatlán Processing Plant in Puebla, Mexico, advancing the company’s pathway toward near-term antimony production | Announcement:
https://t.co/Ah4f7arb0G @EVResources_EVR $EVR
Epiminder (ASX:EPI) has reached a key milestone in its DETECT clinical study, announcing the enrolment of its 25th patient as momentum continues to build across the United States.
ASX announcement: https://t.co/pYNVAZXS9e
_ @4DMedicalXV (ASX:4DX) has entered the US outpatient market through a commercial agreement with @SimonMedImaging, extending CT:VQ™ across a 170+ site network.
ASX announcement: https://t.co/OPdDahBwEb
Kincora Copper is focused on executing its strategy of more drilling and more deals.
Sign up here to Kincora’s distribution list to receive updates directly: https://t.co/MoD7ZMallG
$KCC.V $KCC.AU $KCC @KincoraCopper
_ @OncoSil_Medical (ASX:OSL) has secured key ethics approval in Italy for its OSPRItaly post-market clinical registry, supporting a broader commercial rollout of the OncoSil™ device across this major European country.
ASX announcement: https://t.co/L5ipqUWRq2
Acrux (ASX:ACR) has expanded its licensing agreement with Gedeon Richter Plc for Lenzetto® in the Australian market.
ASX announcement: https://t.co/ZiqO8Ke3MA
Alcidion Group (ASX:ALC) has signed a seven-year contract with University Hospitals Sussex NHS Foundation Trust to deploy its Miya Precision Electronic Patient Record (EPR) platform | Announcement:
https://t.co/43Lmeqp6jo @alcidion $ALC
_ @OncoSil_Medical (ASX:OSL) says Spanish clinical experience with the OncoSil™ device has been accepted for poster presentation at the 2026 ASCO Annual Meeting in Chicago, highlighting growing recognition in unresectable LAPC.
https://t.co/XOQkmu738T
_ @KincoraCopper CEO Sam Spring joined Liberty and Finance to discuss the growing global copper supply deficit, rising demand from electrification, decarbonisation & KCC's exploration strategy in NSW alongside major industry partners.
Watch here: https://t.co/5cygc1rKmp
_ @EBRSystemsInc (ASX:EBR) has secured a three-year purchasing agreement with CHRISTUS Health, supporting the continued U.S. commercial rollout of its WiSE® CRT System.
ASX announcement: https://t.co/oeqb7tYEQw
_ @KincoraCopper (ASX & TSXV:KCC) has received a US$1.5 million non-refundable option payment as part of a staged divestment of its Mongolian subsidiaries.
ASX announcement: https://t.co/OSb1cgxFgC
_ @OncoSil_Medical (ASX:OSL) has received TGA approval for the OncoSil™ device in Australia, marking a major milestone for the Australian-developed pancreatic cancer treatment technology.
ASX Announcement: https://t.co/KTHuzR14HF